Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Bonini

Showing results (41-50 of 183) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|December 26, 2015
High SPARC Expression Starting from Dysplasia, Associated with Breast Carcinoma, Is Predictive for Bone Metastasis without Enhancement of Plasma LevelsPaola Maroni, Paola Bendinelli, Daniele Morelli, et al.
The International Journal of Biological Markers|November 7, 2015
Androgen receptor CAG repeat length and estrogen receptor status in postmenopausal breast cancer prognosisPatrizia Cogliati, Chiara Maura Ciniselli, Roberto Agresti, et al.
Frontiers in Immunology|October 5, 2020
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and GoalsFrancesco Manfredi, Beatrice Claudia Cianciotti, Alessia Potenza, et al.
Immunology|September 6, 2023
Interleukin-7 improves the fitness of regulatory T cells for adoptive transferIlaria Cosorich, Jessica Filoni, Carla Di Dedda, et al.
Frontiers in Immunology|November 9, 2020
New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future DirectionsNathaniel Edward Bennett Saidu, Chiara Bonini, Anne Dickinson, et al.
Frontiers in Immunology|July 9, 2020
Next-Generation Manufacturing Protocols Enriching T<sub>SCM</sub> CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer PatientsSilvia Arcangeli, Laura Falcone, Barbara Camisa, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
Expert Review of Proteomics|October 27, 2015
Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferroneChiara Maura Ciniselli, Maida De Bortoli, Elena Taverna, et al.
Frontiers in Immunology|April 6, 2018
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide GeneMonica Casucci, Laura Falcone, Barbara Camisa, et al.
Cancer Research|April 15, 2010
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumorsRodrigo Hess Michelini, Massimo Freschi, Teresa Manzo, et al.
Pageof 19

Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|December 26, 2015
High SPARC Expression Starting from Dysplasia, Associated with Breast Carcinoma, Is Predictive for Bone Metastasis without Enhancement of Plasma LevelsPaola Maroni, Paola Bendinelli, Daniele Morelli, et al.
The International Journal of Biological Markers|November 7, 2015
Androgen receptor CAG repeat length and estrogen receptor status in postmenopausal breast cancer prognosisPatrizia Cogliati, Chiara Maura Ciniselli, Roberto Agresti, et al.
Frontiers in Immunology|October 5, 2020
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and GoalsFrancesco Manfredi, Beatrice Claudia Cianciotti, Alessia Potenza, et al.
Immunology|September 6, 2023
Interleukin-7 improves the fitness of regulatory T cells for adoptive transferIlaria Cosorich, Jessica Filoni, Carla Di Dedda, et al.
Frontiers in Immunology|November 9, 2020
New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future DirectionsNathaniel Edward Bennett Saidu, Chiara Bonini, Anne Dickinson, et al.
Frontiers in Immunology|July 9, 2020
Next-Generation Manufacturing Protocols Enriching T<sub>SCM</sub> CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer PatientsSilvia Arcangeli, Laura Falcone, Barbara Camisa, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
Expert Review of Proteomics|October 27, 2015
Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferroneChiara Maura Ciniselli, Maida De Bortoli, Elena Taverna, et al.
Frontiers in Immunology|April 6, 2018
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide GeneMonica Casucci, Laura Falcone, Barbara Camisa, et al.
Cancer Research|April 15, 2010
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumorsRodrigo Hess Michelini, Massimo Freschi, Teresa Manzo, et al.
Pageof 19